Medicare Advantage (MA) provides beneficiaries an option to receive Medicare benefits from private plans.
Although MA covers over half of the Medicare population, limited information exists about how utilization of cancer treatments in MA differs from traditional Medicare (TM).
We compared use of low-value cancer treatments between MA and TM and analyzed variation in use of low-value cancer treatments across large MA insurers.
